|
Private Placement (Details 2) (USD $)
|
3 Months Ended | 12 Months Ended |
|---|---|---|
|
Mar. 31, 2014
|
Dec. 31, 2013
|
|
| Private Placement [Line Items] | ||
| Derivative Liability, Current | $ 34,268,000 | $ 6,277,000 |
|
Consulting Warrant [Member]
|
||
| Private Placement [Line Items] | ||
| Stock price on valuation date | $ 14.75 | $ 1.68 |
| Exercise price | $ 0.04 | $ 0.04 |
| Term (years) | 4 years 1 month 17 days | 4 years 4 months 17 days |
| Expected volatility | 60.00% | 60.00% |
| Dividend yield | 0.00% | 0.00% |
| Weighted average risk-free interest rate | 1.32 | 1.75 |
| Number of warrants | 278,228 | 278,228 |
| Number Of Trials | 20,000 | 20,000 |
| Derivative Liability, Current | 4,045,000 | 529,000 |
|
Financing Warrant [Member]
|
||
| Private Placement [Line Items] | ||
| Stock price on valuation date | $ 14.75 | $ 1.68 |
| Exercise price | $ 3.60 | $ 2.49 |
| Term (years) | 4 years 1 month 17 days | 4 years 4 months 17 days |
| Expected volatility | 60.00% | 60.00% |
| Dividend yield | 0.00% | 0.00% |
| Weighted average risk-free interest rate | 1.32 | 1.75 |
| Number of warrants | 152,778 | 220,905 |
| Number Of Trials | 20,000 | 20,000 |
| Derivative Liability, Current | $ 1,764,000 | $ 175,000 |
| X | ||||||||||
|
- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Agreed upon price for the exchange of the underlying asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Price of a single share of a number of saleable stocks of a company. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Represents the number of trials used in measurement of fair values. No definition available.
|
| X | ||||||||||
|
- Definition
Represents number of warrants used in measurement of fair values. No definition available.
|
| X | ||||||||||
|
- Details
|